Learn More
Prompted by the 20th anniversary of the 1993 World Development Report, a Lancet Commission revisited the case for investment in health and developed a new investment framework to achieve dramatic health gains by 2035. The Commission's report has four key messages, each accompanied by opportunities for action by national governments of low-income and(More)
  • S Noorani, L Alyanak, V Suvorov, Betty Press, L Taylor, J Maillard +43 others
  • 2007
©Joint United Nations Programme on HIV/AIDS (UNAIDS) 2007. All rights reserved. Publications produced by UNAIDS can be obtained from the UNAIDS Information Centre. Requests for permission to reproduce or translate UNAIDS publications — whether for sale or for non-commercial distribution —should be addressed to the Information Centre at the address below or(More)
The Global HIV Prevention Working Group is a panel of over 50 leading public health experts, clinicians, biomedical and behavioral researchers, advocates and people affected by HIV/AIDS, convened by the Bill & Melinda Gates Foundation and the Henry J. Kaiser Family Foundation. The Working Group seeks to inform global policy-making, program planning, and(More)
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to increase the pace, reduce the overlap, and more systematically explore the elements of and delivery systems for vaccines; (iii) to use common standards for the prompt comparative testing of vaccine candidates; (iv) to expand resources for manufacturing vaccine(More)
Sustaining a growing ageing population across the European region through integrated health policies that put citizens at the centre of the health-care process can achieve improvements in the health and wellbeing of citizens in coming decades. I declare that I have no confl icts of interest. 1 Mackenbach J, McKee M. Successes and failures of health policy(More)
Over the last 4 years, a remarkable public health success has unfolded in Africa. The field introduction of a new group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), has been a stunning success, with the virtual disappearance of group A meningococcal meningitis in sub-Saharan Africa. The effort began with a plea from African ministers of health to(More)